Alterity Therapeutics Ltd News

Alterity Therapeutics Ltd: Change of Share Registry

Oct 3 23:05 ET

Alterity Therapeutics Ltd: Alterity Data Presentations at MDS Congress Raises Profile

Oct 1 21:43 ET

Alterity Therapeutics Ltd: Alterity Therapeutics Filed Form 20-F and XBRL data with SEC

Sep 29 23:32 ET

Alterity Therapeutics Ltd: ATH Appoints Abby Macnish Niven as Chief Financial Officer

Sep 29 19:00 ET

Alterity Therapeutics Ltd: Appendix 4G

Sep 25 23:20 ET

Alterity Therapeutics Ltd: Corporate Governance Statement

Sep 25 23:15 ET

Alterity Therapeutics Ltd: Alterity to Deliver Multiple Presentations at MDS Congress

Sep 22 19:33 ET

Alterity Therapeutics Ltd: Change of Director's Interest Notice - BM / PM

Sep 19 18:17 ET

Alterity Therapeutics Ltd: Quarterly Activities/Appendix 4C Cash Flow Report

Jul 30 18:12 ET

Alterity Therapeutics Ltd: Alterity Therapeutics to Present at MST Financial Webinar

Jul 23 21:15 ET

Alterity Therapeutics Ltd: Positive Interim Data from ATH434-202 Phase 2 Clinical Trial

Jul 16 20:20 ET

Alterity Therapeutics Ltd: Trading Halt

Jul 14 19:25 ET

Alterity Therapeutics Ltd: Alterity to Present at Hidden Gems in Life Sciences Webinar

Jun 12 18:42 ET

Alterity Therapeutics Ltd: Phase 2 DMC Recommends Continuing Clinical Trial as Planned

May 7 18:27 ET

Alterity Therapeutics Ltd: Quarterly Activities/Appendix 4C Cash Flow Report

Apr 29 19:06 ET

Alterity Therapeutics Ltd: Alterity Presents New Data on ATH434

Apr 28 18:41 ET

Alterity Therapeutics Ltd: Alterity Parkinson's and MSA Data Featured at AAN Meeting

Apr 16 18:48 ET

Alterity Therapeutics Ltd: Alterity to Present New ATH434 Data at Orphan Drug Congress

Apr 9 18:35 ET

Alterity Therapeutics Ltd: Alterity Receives a $3.9 million R&D Tax Incentive Refund

Mar 25 22:15 ET

Alterity Therapeutics Ltd: Trading Halt

Feb 21 16:52 ET